We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Calls for Nominations of Difficult to Compound Drugs

16 December 2013

Pharmaceutical and Biotechnology Alert

The U.S. Food and Drug Administration (FDA) is required by statute to maintain a list of drug products that cannot be manufactured by pharmaceutical compounding because they are demonstrably difficult to compound. In a notification released on Wednesday, 4 December, the FDA announced that it is accepting nominations for drug products to include on the list. In order to be considered for the inaugural list, nominations must be received by 4 March 2014.

Read More: FDA Calls for Nominations of Difficult to Compound Drugs

The team

Loading data